While investigations continue, both the TGA and the Australian Technical Advisory Group on Immunisation (ATAGI) have said no change to Australia's vaccine rollout was needed.
That's despite rising cases of rare blood clots possibly linked to the jab.
AstraZeneca Plc said the review of safety data of people vaccinated with its Covid-19 vaccine has shown no evidence of an increased risk of blood clots.
"Nevertheless, the extreme rarity of these events in the context of the many millions of vaccine doses that have been administered means that the risk-benefit decision facing people who are invited to receive Covid-19 vaccines is very straight forward: receiving the vaccine is by far the safest choice in terms of minimising individual risk of serious illness or death".
"Don't worry because we have medicine to treat allergies such as muscle pain, fever or itchiness", he said in a news conference at the Back to School Haircut Programme for schools in the Bagan Serai parliamentary constituency at the Pusat GiatMara Bagan Serai here today.
The woman, a social worker, who was vaccinated in mid-March due to her work at a centre with disabled people - did not suffer from any particular health problems, added Boittin.
"My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca,"Fauci said".
The British acknowledgment of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.
United Kingdom records more AstraZeneca blot cases and seven die as a result, Argentine president tests positive and the USA vaccinates more than 1 million people.
In a statement, the government said there had been five reports of thrombosis and abnormally low platelets, which help blood clot, in women aged 25 to 65 (around 400,000 AstraZeneca injections have been given in the Netherlands, according to the same government statement).
Ontario back into shutdown starting April 3
New modelling also shows Ontario could have up to 6,000 new cases a day by the end of April due to the new variants of the virus. Essential retail stores are capped at 50 per cent of their maximum capacity and non-essential stores are limited to 25 per cent.